The human epidermal growth factor receptor 2 (HER-2) gene is an oncogene involved in the growth and progression of tumors, and it has become an important indicator for assessing the prognosis and guiding the treatment of malignant tumors, such as breast cancer and gastric cancer (21). This evidence concerns the gene ERBB2 and breast cancer.